Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R > Treatment > Co: USA. A. Brand Ibrutinib>

---

Co: USA. A. Brand Ibrutinib>'s subsections
(*) USA Approval Date: 2013. 11.13.
>Received >1 Prior Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 35
Patent>UpDate: 2018. 11.06.
TradeMark
TradeMark Web-Site

Co: USA. A. Brand Ibrutinib>'s products
This section has no products